Search Results

ST 101(ZSET1446) 5mg 5mg  | Purity Not Available

Adooq Bioscience

ST 101 (ZSET1446) is a novel cognitive enhancer that promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice.

More Information Supplier Page

ST 101(ZSET1446) 25mg 25mg  | Purity Not Available

Adooq Bioscience

ST 101 (ZSET1446) is a novel cognitive enhancer that promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice.

More Information Supplier Page

ST 101(ZSET1446) 10mg 10mg  | Purity Not Available

Adooq Bioscience

ST 101 (ZSET1446) is a novel cognitive enhancer that promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice.

More Information Supplier Page

CNX-2006 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

CNX-2006 is a potent, mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation. CNX-2006 is the prototype for CO-1686, which is currently in a Phase I clinical trial for the treatment of EGFR-mutant lung cancer.

More Information Supplier Page

CNX-2006 100mg 100mg  | Purity Not Available

Adooq Bioscience

CNX-2006 is a potent, mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation. CNX-2006 is the prototype for CO-1686, which is currently in a Phase I clinical trial for the treatment of EGFR-mutant lung cancer.

More Information Supplier Page